Basal cell carcinoma of skin of lip
ICD-10 C44.01 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of lip.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. When it occurs on the lip, it presents unique challenges due to the anatomical and functional significance of this area. BCC on the lip is often linked to chronic sun exposure, which damages the skin's DNA and leads to uncontrolled cell growth. Clinically, it may appear as a pearly or waxy bump, a flat, flesh-colored lesion, or a sore that doesn't heal. Surgical excision is the primary treatment, and achieving clear surgical margins is crucial to prevent recurrence. Reconstruction may be necessary, especially for larger lesions, to restore both function and aesthetics. The prognosis for BCC is generally favorable, but careful monitoring is essential due to the potential for local invasion and the risk of developing additional skin cancers in sun-exposed areas.
Detailed descriptions of the lesion, treatment plan, and follow-up care.
Diagnosis and treatment of BCC, Mohs micrographic surgery, and post-operative care.
Ensure clear documentation of margins and any additional procedures performed.
Comprehensive records of reconstructive procedures and aesthetic outcomes.
Reconstruction after excision of BCC on the lip, including flap or graft techniques.
Document the functional and cosmetic outcomes of reconstruction.
Used when excising a BCC from the lip.
Document size, location, and margins of the excised lesion.
Dermatologists should ensure accurate coding of excised margins.
The primary treatment is surgical excision, often followed by reconstruction if necessary. Mohs micrographic surgery is also a common approach for ensuring clear margins.
